Brookfield had its Relative Strength (RS) Rating upgraded from 79 to 82 Monday.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary rating tracks price action with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the best-performing stocks tend to have an 80 or higher RS Rating in the early stages of their moves.
Brookfield is working on a cup without handle with a 62.78 buy point. See if the stock can clear the breakout price in volume at least 40% above average.
Earnings growth increased in the company's latest report from 15% to 22%, but the top line fell from -16% to -21%. Keep an eye out for the company's next round of numbers on or around May 8.
Brookfield holds the No. 70 rank among its peers in the Finance-Investment Management industry group. Sprott, Acadian Asset Management and P10 are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
